Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06029465

Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials

Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials: A Study of Participation Patterns Among Those Affected by the Disorder

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Power Life Sciences Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study seeks to delve into the firsthand experiences of patients diagnosed with rhabdomyosarcoma who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. The data collected from this study will help improve future outcomes for all rhabdomyosarcoma patients as well as those in under-represented demographic groups.

Conditions

Timeline

Start date
2024-10-01
Primary completion
2025-10-01
Completion
2026-10-01
First posted
2023-09-08
Last updated
2023-09-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06029465. Inclusion in this directory is not an endorsement.

Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials (NCT06029465) · Clinical Trials Directory